Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$615K Buy
1,191,977
+178,921
+18% +$107K 0.06% 143
2026
Q1
$637K Buy
1,013,056
+124,211
+14% +$93.5K 0.07% 138
2025
Q4
$780K Buy
888,845
+107,592
+14% +$115K 0.09% 128
2025
Q3
$1.06K Buy
781,253
+99,069
+15% +$150K ﹤0.01% 170
2025
Q2
$1.07M Buy
682,184
+43,784
+7% +$81.6K 0.13% 111
2025
Q1
$1.69M Buy
638,400
+14,472
+2% +$58.1K 0.21% 96
2024
Q4
$2.65M Sell
623,928
-14,100
-2% -$54.3K 0.32% 82
2024
Q3
$2.12M Sell
638,028
-161,268
-20% -$548K 0.25% 93
2024
Q2
$2.47M Buy
799,296
+195,428
+32% +$643K 0.29% 98
2024
Q1
$2.44M Buy
603,868
+377,462
+167% +$1.42M 0.28% 96
2023
Q4
$1.27M Buy
226,406
+19,370
+9% +$111K 0.16% 107
2023
Q3
$1.1M Buy
207,036
+29,263
+16% +$238K 0.16% 110
2023
Q2
$1.67M Buy
+177,773
New +$1.56M 0.23% 93

Other funds holding DCGO

Isthmus Partners's DCGO Position: Q2 2026 in Review

Isthmus Partners increased its DocGo (DCGO) stake by 18% in Q2 2026, buying an estimated $107K and bringing the position to 1,191,977 shares worth $615K. The position accounts for 0.06% of the portfolio, ranked #143.

Isthmus Partners first reported a position in DCGO in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.65M in Q4 2024. 16 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • Isthmus Partners held 1,191,977 shares of DocGo worth $615K as of Q2 2026.
  • Isthmus Partners bought 178,921 DocGo shares in Q2 2026, an estimated $107K.
  • DocGo made up 0.06% of Isthmus Partners's portfolio in Q2 2026, its #143 holding.
  • Isthmus Partners first reported a position in DocGo in Q2 2023 and has held it in 13 quarters since.
  • Isthmus Partners's DocGo position peaked at $2.65M in Q4 2024.
  • 16 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.